Emerald Mutual Fund Advisers Trust Sage Therapeutics, Inc. Transaction History

Emerald Mutual Fund Advisers Trust

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Jul 31, 2018	SELL	$140.36 - $175.76 $17.8 Million - $22.3 Million	-126,626 Closed	0 $0
Q1 2018 Apr 26, 2018	SELL	$152.15 - $192.33 $1.02 Million - $1.29 Million	-6,697 Reduced 5.02%	126,626 $20.4 Million
Q4 2017 Feb 06, 2018	BUY	$60.72 - $167.34 $4.29 Million - $11.8 Million	70,615 Added 112.61%	133,323 $22 Million
Q3 2017 Oct 30, 2017	BUY	$61.4 - $88.52 $3.85 Million - $5.55 Million	62,708	62,708 $3.91 Million

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $323M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Emerald Mutual Fund Advisers Trust, based on Form 13F filings with the SEC.

Stay updated on Emerald Mutual Fund Advisers Trust with notifications on news.